We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+16.37%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
AUM
$375M
AUM Growth
-$66.5M
Cap. Flow
-$113M
Cap. Flow %
-30.22%
Top 10 Hldgs %
49.42%
Holding
101
New
26
Increased
13
Reduced
31
Closed
29

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$26.2M
2
PFE icon
Pfizer
PFE
+$20.2M
3
LBTYA icon
Liberty Global Class A
LBTYA
+$14.9M
4
ETN icon
Eaton
ETN
+$14.3M
5
CBRE icon
CBRE Group
CBRE
+$13.8M

Sector Composition

Rank Sector Weight
1 Healthcare 27.94%
2 Industrials 13.14%
3 Communication Services 12.29%
4 Consumer Discretionary 9.78%
5 Real Estate 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOLC
51
DELISTED
VOLCANO CORPORATION COM STK
VOLC
$431K 0.11%
17,984
-25,202
-58% -$537K
COO icon
52
Cooper Companies
COO
$14.3B
$377K 0.1%
11,624
-1,276
-10% -$41.2K
HUM icon
53
Humana
HUM
$44.1B
$358K 0.1%
+3,834
New +$352K
EPZM
54
DELISTED
Epizyme, Inc
EPZM
$346K 0.09%
8,647
-5,240
-38% -$177K
AGN
55
DELISTED
Allergan plc
AGN
$295K 0.08%
2,048
-61,553
-97% -$8.2M
CFN
56
DELISTED
CAREFUSION CORPORATION
CFN
$280K 0.07%
7,587
-3,362
-31% -$126K
RAD
57
DELISTED
Rite Aid Corporation
RAD
$276K 0.07%
2,896
+1,159
+67% +$79.1K
MOH icon
58
Molina Healthcare
MOH
$10B
$275K 0.07%
7,712
-3,003
-28% -$111K
VTRS icon
59
Viatris
VTRS
$19B
$274K 0.07%
+7,188
New +$253K
GNMK
60
DELISTED
GenMark Diagnostics, Inc
GNMK
$242K 0.06%
19,968
-749
-4% -$8.03K
BHC icon
61
Bausch Health
BHC
$2.21B
$200K 0.05%
1,915
-7,997
-81% -$779K
AGIO icon
62
Agios Pharmaceuticals
AGIO
$1.91B
$178K 0.05%
+6,366
New +$176K
BLUE
63
DELISTED
bluebird bio
BLUE
$164K 0.04%
+470
New +$175K
SIRO
64
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
$145K 0.04%
2,173
-65,240
-97% -$4.4M
WAT icon
65
Waters Corp
WAT
$39.2B
$141K 0.04%
1,323
-112
-8% -$11.5K
MYGN icon
66
Myriad Genetics
MYGN
$304M
$106K 0.03%
+4,530
New +$129K
WAT icon
67
CALL
Waters Corp
WAT
$39.2B
$15K ﹤0.01%
+10,100
New +$1.04M
RPRX
68
CALL
DELISTED
Repros Therapeutics Inc.
RPRX
$4K ﹤0.01%
+5,200
New +$111K
MRK icon
69
CALL
Merck
MRK
$317B
$3K ﹤0.01%
14,672
-6,917
-32% -$316K
MYGN icon
70
CALL
Myriad Genetics
MYGN
$304M
$3K ﹤0.01%
+6,000
New +$170K
ALGN icon
71
Align Technology
ALGN
$12B
-12,975
Closed -$481K
AMCX icon
72
AMC Global Media
AMCX
$490M
-93,156
Closed -$6.09M
BB icon
73
BlackBerry
BB
$5.15B
-3,893
Closed -$41K
BIIB icon
74
Biogen
BIIB
$30.5B
-3,292
Closed -$708K
BWA icon
75
BorgWarner
BWA
$13.4B
-217,821
Closed -$8.26M

Similar funds

Partner Investment Management's Q3 2013 Portfolio in Review

As of Q3 2013, Partner Investment Management held 101 positions worth $375M, down 15% from $442M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Partner Investment Management withdrew a net $113M in Q3 2013, closing 29 positions and reducing 31 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $26.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Industrials and Communication Services.

Against the trend, Partner Investment Management opened a new position in Adobe worth $11M.

  • Partner Investment Management's largest Q3 2013 buy was Adobe: 211,787 shares worth $11M.
  • Partner Investment Management added most to CAMERON INTERNATIONAL CORPORATION in Q3 2013, an estimated $8.25M increase.
  • Partner Investment Management's biggest Q3 2013 reduction was Pfizer, cutting an estimated $20.2M.
  • Partner Investment Management fully exited Alphabet (Google) Class C in Q3 2013, selling an estimated $26.2M.
  • Partner Investment Management's ten largest holdings make up 49% of its $375M portfolio in Q3 2013.
  • Partner Investment Management opened 26 new positions and closed 29 in Q3 2013.
  • Partner Investment Management's portfolio value fell 15% quarter-over-quarter to $375M.

Based on Partner Investment Management's 13F filing for Q3 2013, filed 14 Nov 2013.